HØST PtX Esbjerg, developed by CIP, celebrates the Danish government’s recent announcement about the planned hydrogen pipeline between Denmark and Germany, set for completion in 2030. This milestone ...

Iberdrola achieved significant milestones in 2024, setting records in electricity distribution, renewable generation, and green capacity. The com ...

The Berlin Fashion Hub have unveiled the 10 finalists of the 2024-2025 Design Academy, a program that champions adaptive fas ...

Roche has announced that the FDA has expanded the approval of its PATHWAY® HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test to identify HE ...

HØST PtX Esbjerg, developed by CIP, celebrates the Danish government’s recent announcement about the planned hydrogen pipeline between Denmark and Germany, set for completion in 2030. This milestone ...

Roche has announced that the FDA has expanded the approval of its PATHWAY® HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test to identify HER2-ultralow status in HR-positive, HER2-negative ...

The Berlin Fashion Hub have unveiled the 10 finalists of the 2024-2025 Design Academy, a program that champions adaptive fashion for individuals with disabilities. The program, which ran from April ...

Roche has announced that the FDA has expanded the approval of its PATHWAY® HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test to identify HER2-ultralow status in HR-positive, HER2-negative ...

Roche has announced that the FDA has expanded the approval of its PATHWAY® HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test to identify HER2-ultralow status in HR-positive, HER2-negative ...

A national study led by the University of Bristol has revealed that both the public and divorcees themselves have limited knowledge about the leg ...

Warwick Conferences, part of the University of Warwick, has introduced several initiatives aimed at promoting sustainability in the events and ho ...

Sarclisa (isatuximab) has been approved in China for use in combination with the VRd regimen to treat newly diagnosed multiple myeloma patients w ...